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A soluble galactosyltransferase was purified 22,000-fold from bovine cornea. The enzyme 
catalyzes the transfer of galactose from UDP-galactose to N-aCetyl-D-glUCOSamine, ay and pm 
glucosaminides, bovine cornea and nasal septum agalactokeratan, and to glycoproteins 
containing terminal nonreducingN-acetylglucosaminyl units. When N-acetyl-n-glucosamine 
served as acceptor, the product formed by the cornea transferase contained galactose 
glycosidically linked to carbon atom 4 ofN-acetyl-D-glucosamine; the same glycosidic linkage 
was found in [‘%]keratan preparations isolated from reaction mixtures where keratan 
containing terminal nonreducing N-acetylglucosaminyl units served as acceptor. The cornea 
enzyme exhibited a markedly lower K, with keratan than with N-aCetyl-D-glUCoSamine. 
The physical and kinetic properties of the cornea galactosyltransferase and of the milk 
A-protein (A-protein + a-la&albumin = lactose synthase), including modulations of accep- 
tor specificity by ol-lactalbumin, were compared. The results of these studies strongly 
suggest that the two glycosyltransferases are similar, if not identical. Efforts to dcmon- 
strate the presence of other soluble galactosyltransferases in cornea were unsuccessful; 
no change in the ratios of products formed with several acceptors was observed at any stage 
of purification. It is suggested that in bovine tissues a single galactosyltranaferase partici- 
pates in the synthesis of both high and low molecular weight galactosides including the 
assembly of the repeating disaccharide [O-P-galactopyranosyl-(1 + 4)-N-acetylglucosamine] 
of cornea keratan sulfate. 
Keratan sulfate is composed of 8 to 
15 repeating disaccharide units of O-p- 
galactosyl-( 1 + 4)-N-acetylglucosamine 
polymerized through p,l + 3 glycosidic 
linkages and is classified as a glycosamino- 
glycan (1, 2). Approximately 50% of the 
galactose residues and 60% of the N- 
acetylglucosamine residues are randomly 
substituted with ester sulfate groups at 
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carbon atom 6 (3). In cornea, the keratan 
sulfate chains are linked to protein through 
N-glycosidic bonds to asparagine residues 
(4), while in cartilage the linkage is through 
0-glycosidic bonds to serine and/or threonine 
residues (3,5-7). Keratan sulfate comprises 
about 7% of the total glycosaminoglycan 
content of cartilage and over 70% in cornea 
tissue; hence, most studies dealing with the 
biosynthesis of keratan sulfate have been 
carried out with cornea tissue (8, 9). In con- 
trast to other glycosaminoglycans, little is 
known concerning the specific steps in the 
biosynthesis of keratan sulfate. 
In this article, we report the isolation and 
extensive purification of a soluble galactosyl- 
transferase from bovine cornea that cata- 
lyzes the transfer of galactose to N-acetyl- 
glucosamine, keratan, and glycoproteins 
containing terminal nonreducing N-acetyl- 
glucosamine residues. The physical and 
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kinetic properties of cornea galactosyltrans- 
ferase are presented and compared to those 
of the A-protein of milk. A preliminary 
communication reporting some aspects of 
these studies has been published (10). 
MATERIALS AND METHODS 
UDP-[ U-‘4C]galactose (274 &i/Fmol) was obtained 
from the New England Nuclear Co., Boston, Mas- 
sachusetts, and nonradioactive UDP-Gal was from 
Sigma Chemical Co., St. Louis, Missouri. Dowex l-X2 
(Cl-) and Dowex 50-X8 (H’), each 200 to 400 mesh, 
were purchased from BioRad Laboratories, Richmond, 
California. Galactose dehydrogenase was obtained from 
Boehringer-Mannheim, New York, New York; 
Sephadex and Sepharose 4B were from Pharmacia, 
Piscataway, New Jersey; a-lactalbumin (crystallized 
3x, Lot No. #C8437) was from Gallard Schlesinger 
Chemical Manufacturing Co., Carle Place, New York; 
and frozen bovine eyes were from Standard Beef, 
Detroit, Michigan. 2-Acetamido-‘%‘-(L-aspart-4-oyl)- 
1,2-dideoxy-P-D-glucose” was purchased from Cycle 
Chemical Co., Los Angeles, California. Bacterial 
chondroitinases and chondrosulfatases were obtained 
from Miles Laboratory, Elkhart, Indiana. Acylneur- 
aminyl hydrolase (EC 3.2.1.18) was isolated from 
Clostridiurn perfi-ingellx as described by Cassidy 
et nl. (11) and bovine testicular P-galactosidase was 
prepared as described by Distler and Jourdian (12). 
Crystalline papain was prepared by an affinity chroma- 
tography procedure (13). u-Lactalbumin-substituted 
agarose (4.3 mg of protein/ml of settled Sepharose) u-as 
prepared by the method of Trayer and Hill (14). 
The following compounds were generous gifts: the 
1 + 4. 1 + 3, and 1 + 6 isomers of galactosyl 
N-acetylglucosamine, Dr. Adeline Gauhe. Max-Planck 
Institute, Heidelberg; methyl 2-acetamido-2-deoxy-a- 
glucoside. methyl 2-acetamido-2deoxy-p-glucoside. 
methyl 2-bromo-acetamido-2-deoxy-/-glucoside, 
methyl 2.deoxy-2-(p-nitrobenzamido)+-glucoside, di- 
N-acetylchitobiose, and tri-N-acetylchitotriose, Dr. 
Irwin Goldstein, The University of Michigan; 2. 
acetamido-N-(L-aspart-4-oyl)-l,2-dideoxy-P-galactose, 
Dr. I. Yamashina, Kyoto University, Tokyo; orosomu- 
’ All glycoses were of the D configuration and were 
pyranosides unless otherwise specified. The accepted 
nomenclature for disaccharides such as N-acetyllactos- 
amine and lactose is 4-O-P-D-galactopyranosyl-2- 
acetamido-2-deoxy-D-glucose and 4-O-P-D-g&do- 
pyranosyl-D-glucose, respectively. For purposes of 
simplicity, these compounds are designated galactosyl- 
@, 1 + 4)-N-acetylglucosamine and galactosyl-(P, 1 
+ 4).glucose. Similar nomenclature is used for other 
disaccharides. The prefix “agalacto” refers to prior 
treatment of compounds such as keratan with p- 
galactosidase to remove galactose. 
coid (cu,-glycoprotein) and asialo-orosomucoid, Dr. Karl 
Schmid, Boston University; and crude heparinase, 
Dr. A. Linker, University of Utah. 
Ar~xzlytical technig%es. Protein concentrations were 
measured by ultraviolet light absorption (15) or by the 
method of Lowry et al. (16). The concentrations of the 
purified enzyme solutions were determined using the 
extinction coefficient EO.“” LHO nm = 1.61 (14). Carbohy- 
drates and carbohydrate derivatives were determined 
by the following procedures: bound galactose after 
resin-mediated acid hydrolysis by gas-liquid chroma- 
tography of the corresponding 0-acetylglycitol deriva- 
tive (17) or with an anthrone reagent (18); free 
galactose by galactose dehydrogenase (12); hexosamines 
by a modified Elson-Morgan procedure (19); sulfate by 
a barium chloroanilate procedure (20); and glucuronic 
acid by the method of Dische (21). Uridine 5’.diphosphate 
was quantitated by ultraviolet absorption at 262 nm. 
Disc gel electrophoresis was performed in the pres- 
ence of sodium dodecyl sulfate as described by Weber 
and Osborn (22); protein bands were detected by 
Coomassie brilliant blue stain. Chymotrypsinogen. 
ovalbumin, bovine serum albumin (Schwartz/Mann, 
Orangeburg, New York), and lactate dehydrogenase 
(Boehringer-Mannheim Corp.) served as molecular 
weight standards. 
Paper chromatograms were irrigated in a descending 
fashion on Whatman No. 3MM paper with S’olvem A, 
r,-butyl alcohol:ethyl alcoholwater (10:1:2), for 120 h or 
on Whatman No. 1 paper developed in multiple de- 
scending fashion with Solz~enf B, n-butyl alcohol: 
pyridine:O. 1 N hydrochloric acid (5:3:2), for 4, 9, and 
12 h. Reducing sugars were detected on chromatograms 
with an aniline-trichloroacetic acid spray reagent (23) 
and N-acetylhexosamines with an alkaline spray 
reagent (24). 
High-voltage electrophoresis was performed on a 
Gilson high-voltage electrophorator on Whatman 
No. 3MM paper saturated with one of the following 
buffers: BufJer C, 1% sodium tetraborate, pH 9.0 
(55 V/cm for 40 min); Buffer D, 1.25 M pyridine in 
0.064 M acetic acid, pH 6.4 (75 V/cm for 30 min); or 
Buffs. E, 1.6 M acetic acid in 0.15 M formic acid, pH 2.1 
(74 V/cm for 70 min). 
Preparation $agalactokeratan sulfate and agalac- 
fokeratan. Keratan sulfate was prepared from bovine 
nasal septum cartilage and bovine cornea by the pro- 
cedure described by Roden et al. (25). Bovine nasal 
septum cartilage keratan sulfate contained 21.6% 
galactose; the galactose to hexosamine to sulfate ratio 
was 1.00:0.90:1.45. Cornea keratan sulfate contained 
34% galactose and the galactose to hexosamine to 
sulfate ratio was 1.00:0.80:1.19. 
Keratan sulfate was desulfated by hydrolysis with 
Dowex 50-X8 (H+) in anhydrous methyl alcohol as de- 
scribed by Bhavanandan and Meyer (3). Ninety-four 
percent of the ester sulfate was removed from the nasal 
septum preparations and 82% from cornea preparations. 
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Each preparation yielded two fractions: a soluble (62%) 
and an insoluble (38%) fraction. The soluble keratan 
was treated with bovine testicular p-galactosidase to 
remove terminal nonreducing galactosyl residues as 
described by Distler and Jourdian (12). Maximum re- 
lease of galactose was achieved after 43 h of incubation; 
22% of the total galactose was released from the nasal 
preparation and 8.2% from the cornea preparation. 
To separate the agalactokeratan from the enzyme and 
the galactose, the reaction mixture was placed on a 
1.2 x 57-cm column of Sephadex G-25 and the column 
was eluted with distilled water. The product was 
detected with anthrone reagent. The content of termi- 
nal N-acetylglucosaminyl residues of the keratan was 
determined by the amount of galactose released on 
treatment with P-galactosidase. 
Assay of galactosyltransferase activity. Typical reac- 
tion mixtures contained the following components (in 
micromoles) in final volumes of 0.05 ml: sodium 
cacodylate-HCl buffer, pH 7.2, 10; N-acetylglucosamine, 
2.5; manganous chloride, 0.2; bovine serum albumin, 
50 pg; UDP-[ U-Y?]Gal (specific activity) approx. 
7 x lo” cpmmol), 0.045; and 0.1 to 0.5 U of galactosyl- 
transferase in 0.1% bovine serum albumin. Reaction 
mixtures were initiated by the addition of UDP-[ U- 
‘?C]Gal and incubated at 37°C for 10 to 30 min, and the 
reaction was terminated by the addition of 10 ~1 of 
0.25 M sodium EDTA in 1% sodium tetraborate. Aliquots 
(25 ~1) were subjected to high-voltage paper electro- 
phoresis in Buffer C. The areas of the electrophoreto- 
grams that corresponded to [Y]acetyllactosamine 
were cut out and the radioactivity was quantitated in a 
Packard liquid scintillation spectrometer as recom- 
mended by the manufacturer. Reaction rates were 
linear with respect to time and enzyme concentration 
provided that less than 10% of the UDP-[ U-“‘C]Gal was 
consumed. One unit of enzyme is defined as that quantity 
that transfers 1 nmol of galactose to N-acetylglucosamine 
per minute at 37°C under the conditions described 
above. 
Purijication of galactosyltransferase from cornea. 
Unless otherwise indicated, all steps were performed 
at 0 to 4°C. 
Step 1. Crude extract: Bovine eyes were allowed to 
thaw partially and the corneas were excised and washed 
in ice water. The corneas were homogenized in 100-g 
batches in a Waring Blendor for 1 min with 400 ml of 
0.05 M Tris-HCl buffer, pH 7.5, containing 0.1 M 
sodium chloride, 5 mM magnesium chloride, and 1 mM 
2-mercaptoethanol. The homogenates from 925 g of 
tissue (1160 eyes) were combined, stirred for 6 h, and 
centrifuged at 18,000g for 15 min. The resulting pre- 
cipitate was resuspended in an additional 400 ml of 
buffer-salts mixture per 100 g of tissue and the suspen- 
sion was stirred for an additional 16 h. The mixture 
was centrifuged and the supernatant solutions were 
combined. 
Step 0. Ammonium sulfate precipitation: The crude 
extract from Step 1 was brought to 35% ammonium 
sulfate saturation by the addition of 19.4 g of ammonium 
sulfate for each 100 ml of crude extract. The mixture 
was stirred for 20 min and centrifuged at 18,000g for 
15 min, and the precipitate was discarded. The super- 
natant was brought to 60% saturation with ammonium 
sulfate (15.1 g/l00 ml) and the precipitate was collected 
by centrifugation. The precipitate was dissolved in a 
minimum volume of the buffer-salts mixture used for 
extraction and the solution was dialyzed for a total of 
24 h against two changes of 10 volumes each of 0.05 M 
Tris-HCI, pH 7.5, containing 5 mM magnesium chloride, 
5 mM N-acetylglucosamine, and 1 mM 2-mercaptoethanol. 
Step 3. Affinity chromatography I: A 2 x 16-cm 
column of the a-lactalbumin-substituted agarose pre- 
pared as described by Trayer and Hill (14) was equili- 
brated with 0.05 M Tris-HCl, pH 7.5, containing 5 mM 
magnesium chloride, 1 mM 2-mercaptoethanol, and 
5 mM N-acetylglucosamine. The dialysate from Step 2 
was passed through the column (flow rate, 18 ml/h) 
and the column was washed with the same buffer until 
the optical density of the eluate at 280 nm was less 
than 0.1. The galactosyltransferase was eluted from 
the column with the same buffer-salts mixture lacking 
N-acetylglucosamine. Fractions of 10 ml were collected 
into tubes containing 0.5 ml of 1 M N-acetylglucosamine, 
a procedure found to stabilize the enzyme. Fractions 
that contained galactosyltransferase activity were 
combined and concentrated in an ultrafiltration cell 
over a Diaflo UM-10 membrane (Amicon Corp., 
Lexington, Massachusetts). 
Affinity chromatography ZZ: Galactosyltransferase 
from affinity column I was applied to a 1 x lo-cm 
column of cu-lactalbumin-substituted agarose at a flow 
rate of 10 ml/h. The column was washed and eluted 
in the same manner as described above for the first 
affinity chromatography column. 
PwQication of lactose synthase A-proteinfrom milk. 
Bovine milk galactosyltransferase (A-protein) was iso- 
lated by a procedure similar to that described for cornea 
galactosyltransferase except that prior to ammonium 
sulfate fractionation casein was removed by isoelectric 
precipitation (26) and cr-lactalbumin was removed by 
gel filtration (27). 
Preparation of [ U-‘4C]Ga/ -Keratan. Agalactokera- 
tan from bovine nasal septum from which an equivalent 
of 0.25 pmol of galactose had been cleaved was added 
to 0.5 ml of imidazole-HCl buffer, pH 8.0 and ionic 
strength 0.5, containing 2 Fmol of manganous chloride, 
0.06 pmol of UDP-[U-‘4C]Gal (1.3 x 10” cpm), and 
0.43 pg of purified bovine cornea galactosyltransferase. 
The mixture was incubated at 37°C for 22 h and the 
entire mixture was placed on a 1.2 x 57-cm column of 
Sephadex G-25. The column was eluted with distilled 
water. [ li-14C]Gal-keratan eluted in the void volume 
and was concentrated to dryness in a rotary evaporator 
at 30°C under reduced pressure. The 14C-labeled 
product contained 3.7 x IO5 cpm of bound [ U-14C]Gal 
(0.017 ymol). No attempt was made to saturate the 
acceptor with l U-Y]Gal. 
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Isolation and culture of‘stronlalfibroblasts. Bovine 
cornea stromal preparations were prepared essentially 
as described by Conrad (28) and the cornea fibroblasts 
were isolated from stroma in the manner described by 
Smith (29). The cells were maintained in Eagle’s mini- 
mum essential medium supplemented with Earle’s salts 
and 10% fetal calf serum (Grand Island Biological Co., 
Grand Island, New York). 
RESULTS 
Purification of Bovine Galactosyltransferaase 
and Milk A-Protein 
The results of the purification of bovine 
cornea galactosyltransferase are summar- 
rized in Table I. The extraction procedure 
yielded a soluble enzyme preparation and 
less than 10% of the total enzyme activity 
was detected in the particulate residue after 
extraction. However, an extended period 
(16 h) was required for the diffusion of the 
enzyme from the gelatinous residue into the 
extracting buffer. Exhaustively extracted 
cornea residue contained less than 2% of the 
galactosyltransferase activity found in the 
soluble fraction. The residue also contained 
small amounts of a second galactosyltrans- 
ferase that catalyzed transfer of galactose 
residues to 34QSxylosyl-L-serine; the latter 
activity is believed to be a galactosyltrans- 
ferase associated with the biosynthesis of 
the linkage region common to several 
glycosaminoglycans (30). 
After ammonium sulfate precipitation, 
the crude cornea enzyme was placed directly 
onto an a-lactalbumin-substituted agarose 
affinity column. The capacity of the affinity 
column to bind the galactosyltransferase 
was not affected by the presence of high 
concentrations of extraneous proteins. For 
example, the application of 10 g of protein 
did not affect binding of the enzyme. Maxi- 
mal enzyme recovery was achieved when 
saturating levels of enzyme (approximately 
1000 U of enzyme/ml of packed a-lactalbumin 
agarose) were used. The cornea galactosyl- 
transferase was purified 22,000-fold (yield, 
17%) and had a specific activity of 10,700 
U/mg of protein. 
The ratios of transferase activity (in the 
presence and absence of a-la&albumin) with 
N-acetylglucosamine, glucose, 2-acetamido- 
N-(L-aspart-4-oyl)-1,2-dideoxy-P-glucose, 
and agalactokeratan as acceptors remained 
constant at each step of the purification. 
Milk A-protein was purified 560-fold from 
milk that was pretreated to remove the 
casein fraction. The purified enzyme had a 
specific activity of 17,134 Uimg of protein; 
this specific activity compares favorably with 
values found by others: 14,100 (14), 5,740 
(31), and 14,900 Uimg of protein (32). 
Homogeneity and Stability of Cornea 
and Milk Galactosyltransferases 
The cornea enzyme yielded a single 
protein-staining band on disc gel electro- 
phoresis columns run in the presence of 
sodium dodecyl sulfate (Fig. 1); the estimated 
molecular weight of the enzyme was 42,200 
? 400. Milk A-protein exhibited two protein 
TABLE I 

















Affinity chromatography I 
Affinity chromatography II 
5,560 29,000 14,100 0.49 100 
447 9,670 12,400 1.28 88 
53 5,020 36 
1.25” 0.222 2,370 10,700 17 
’ Purification based upon extraction of 1160 corneas. 
’ Concentrated by ultrafiltration. 
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FIG 1. Polyacrylamide disc gel electrophoresis of 
cornea galactosyltransferase and milk A-protein in the 
presence of sodium dodecyl sulfate (22). Gel A, 96 U of 
cornea enzyme (9 pg); gel B, 275 U of milk enzyme 
(16 cLg). 
bands with estimated molecular weights of 
53,900 ? 900 and 43,000 + 700, values that 
agree closely with those reported by Barker 
et al. (32) and by Magee et al. (33). Gel 
columns were not loaded with high concen- 
trations of the cornea enzyme since only 
small amounts of purified enzyme were 
available; therefore, it is uncertain if the 
cornea enzyme contains the high molecular 
weight component present in the milk A- 
protein. In addition, when similar protein 
loads of cornea and milk enzymes were 
applied to the gel columns (9 and 16 pg, 
respectively), the cornea enzyme consistently 
stained much less intensely than the milk 
enzyme. 
Trayer and Hill (14) found that the milk 
A-protein was stable at a concentration of 
1.0 mg/ml for at least 3 months when stored 
at 4°C in the presence of a solution contain- 
ing 5 mM manganese chloride, 1 mM 
2-mercaptoethanol, and 5 mM N-acetylglu- 
cosamine. However, the cornea galactosyl- 
transferase at a concentration of 0.18 mg/ml 
lost about 50% of its activity in 1 month 
under these conditions. The cornea enzyme 
could be stored for up to 3 months without 
loss of activity in 0.1% bovine serum albumin. 
Effect of pH and Metal Ions 
The effect of pH on bovine cornea and 
milk galactosyltransferase activities is shown 
in Fig. 2. The pH profile for both enzymes 
is remarkably similar with a broad pH opti- 
mum ranging from 7.5 to 10.5. As indicated 
in the figure, enzyme activity is affected by 
the type of buffer used; this is not attributable 
to differences in ionic strength of the buffers 
employed. The pH profile of bovine milk 
A-protein is similar to that previously re- 
ported (34). 
Cornea galactosyltransferase activity was 
completely dependent upon the presence of 
a divalent cation. Optimal product formation 
was achieved in reaction mixtures that con- 
tained Mn2+ ions at final concentrations of 
4 5 6 7 8 9 IO II 
PH 
FIG. 2. Effect of pH on cornea and milk A-protein 
galactosyltransferase activity with N-acetylglucosamine 
as acceptor. Reaction mixtures were similar to those 
described under Assay of Galactosyltransferases under 
Materials and Methods except that the following buffers 
were used: 0, sodium acetate; 0, sodium cacodylate; 
W, imidazole-HCl; A, glycine; and 0, glycylglycine. 
Each buffer was adjusted to an ionic strength of 0.25 M 
with sodium chloride. Reaction mixtures contained 
0.25 U of cornea enzyme of 0.56 U of milk enzyme 
and were incubated for 15 min. The solid line represents 
cornea enzyme and the dashed line, milk enzyme. 
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4 mM. At the same concentration Co’+ and 
Zn2+ showed considerably lower activity 
(14.9 and 9.2%, respectively), and Mg*+, 
Ca*+ Fe*+, and Na+ gave less than 3% of 
the activity observed with Mn2+ (Table II). 
No measurable change in product formation 
was observed when the final concentration 
of Mn2+ was varied between 2.5 and 1000 mM. 
The cofactor requirements for milk A-protein 
are similar to those found for the cornea 
enzyme. 
Acceptor Specificity Studies 
The cornea and milk galactosyltransferase 
preparations exhibited almost identical 
specificities toward a number of low molecu- 
lar weight acceptor compounds (Table III). 
The addition of a-la&albumin to reaction 
mixtures containing N-acetylglucosamine as 
acceptor inhibited product formation ap- 
proximately 80%, but a-lactalbumin was 
required to demonstrate transfer of galac- 
tosyl residues to glucose. Both (Y- and p- 
methyl glycosides of acetylglucosamine 
served as acceptors; a- and P-methyl glyco- 
sides of glucose did not serve as acceptors 
even in the presence of a-lactalbumin. The 
configurations about carbons 2 and 4 of the 
acceptor compound is of importance as evi- 
TABLE II 
METAL REQUIREMENTSFORBOVINE CORNEA AND 
MILK A-PROTEIN GALACTOSYLTRANSFERASEV 




















” The incubation conditions were those described un- 
der Assay of Galactosyltransferases under Materials and 
Methods, except that imidazole-HCl buffer, pH 8.0 
(ionic strength, 0.5 M), was used. All metal ions were 
added as the chloride salts to a final concentration of 
4 ITIM. 
dented by the inability of N-acetylman- 
nosamine, N-acetylgalactosamine, and 
mannose to serve as acceptor compounds for 
either the milk or the cornea galactosyltrans- 
ferases. The di- and trisaccharides of N- 
acetylglucosamine, di-N-acetylchitobiose 
and tri-N-acetylchitotriose, serve nearly as 
well as acceptors as other glycosides of 
N-acetylglucosamine. 
The acceptor specificity of the cornea and 
milk galactosyltransferases for several high 
molecular weight compounds is also pre- 
sented in Table III. Agalacto-ovomucoid and 
asialo-agalacto-a,-glycoprotein exhibited 
similar acceptor activities with each enzyme 
preparation. The surprisingly high activity 
with agalacto-ovomucoid as acceptor is at- 
tributed to the observation that it may have 
as many as five terminal nonreducing N- 
acetylglucosaminyl residues per mole (35). 
At least a portion of the N-acetylglucosaminyl 
residues in ovomucoid as well as a,-glycopro- 
tein are linked in P-configuration to mannose; 
in keratan N-acetylglucosaminyl residues 
are linked to galactose, and in the chitin 
derivatives to N-acetylglucosamine. The 
demonstrated transfer of galactosyl residues 
to the terminal nonreducing N-acetylglu- 
cosaminyl units of each of these compounds 
suggests that the galactosyltransferase 
exhibits little specificity for the penultimate 
sugar unit or glycosidic bond. 
The results of a comparative study of the 
potential of keratan sulfate and its deriva- 
tives to serve as acceptors for the transfer 
of galactosyl units from UDP-Gal by purified 
cornea1 galactosyltransferase are presented 
in Fig. 3. While the rate of galactosyl trans- 
fer to agalactokeratan sulfate was slower 
than that observed with agalactokeratan, 
about 75% of the potential acceptor sites of 
each compound were glycosylated. As antic- 
ipated, keratan and keratan sulfate, which 
contain terminal galactosyl units, were poor 
acceptors of galactosyl units; that is, the 
14C contents of the reaction products were 
less than 10 and l%, respectively, the value 
obtained with agalactokeratan as acceptor. 
Kinetic Studies 
The K, values for UDP-Gal, cY-lactalbumin, 
Mn2+, and glycosyl acceptors are presented 
in Table IV and are strikingly similar for 
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TABLE III 
ACCEPTORSPECIFICITYOFCORNEAANDMILKGALACTOSYLTRANSFERASESFOR LOWANDHIGH 
























0.67 (0.64)’ 0.43 (0.40)’ 
0.65 (0.55)’ 0.63 (0.58)’ 
0.16 0.08 







” The incubation conditions were those described under Assay of Galactosyltransferases except that imida- 
zole-HCl buffer, pH 8.0 and ionic strength 0.5, was used. The final concentration of each compound tested was 
50 mM except for ovomucoid (0.31 mM), asialo-agalacto-a,-glycoprotein (0.32 mM), cornea1 agalactokeratan 
(0.38 mM), and nasal agalactokeratan (0.33 mM); the concentration of the latter high molecular weight substrates 
is presented as the concentration of terminal N-acetylglucosaminyl groups available to the transferase. 
b The following compounds were inactive in the presence or absence of n-lactalbumin: 2-amino-2-deoxyglu- 
case, 2-acetamido-2-deoxyglucose-l- and -g-phosphate, glucose-l- and -(i-phosphate, u- and P-methyl glucosides, 
3-O-/3-xylosyl-L-serine, 3-O-/3-L-arabinosyl-L-serine, 2-acetamido-N-(L-aspart-4-oyl)-1,2-dideoxy-~-galactoside, 
2-acetamido-2-deoxygalactose, and mannose. 
r Values in parentheses were obtained from incubation mixtures containing 15.5 pg of Lu-lactalbumin in 
place of serum albumin. 
the cornea and milk galactosyltransferases. 
Maximal velocities obtained using glucose 
as acceptor (and in the presence of (Y- 
la&albumin) are also similar for the two 
enzymes. It is of interest that the K, of the 
cornea enzyme for &galactosidase-treated 
keratan is less than one-tenth that obtained 
with N-acetylglucosamine as acceptor and 
approximates the values found for the 
A-protein by other investigators using gly- 
coprotein acceptors such as ovalbumin (37). 
The V and K, values found for the A-protein 
of milk lactose synthase approximate closely 
those previously reported (38). 
Identi,fication of 14C-Labeled Products 
The stoichiometry of the bovine cornea 
galactosyltransferase-catalyzed reaction 
using N-acetylglucosamine as the acceptor 
was determined. The ratio of UDP-[14C]Gal 
consumed to UDP and [ 14C]galactosyl-(/3, 1 
+ 4)- N-acetylglucosamine formed was 1.10: 
1.04:1.10. The 14C-labeled product was 
identified by cochromatography with the 
authentic galactosyl-&?, 1 + 4)-N-acetylglu- 
cosamine in Solvent A, a solvent known to 
separate the three known position isomers 
of acetylglucosamine (39), and by release of 
[14C]galactose on treatment with bovine 
testicular /3-galactosidase. Galactose was 
identified by paper chromatography in 
Systems A and B (Table V) as well as by 
electrophoresis in Buffer C. The demonstra- 
tion of the formation of a /3,1 + 4 glycosidic 
linkage with N-acetylglucosamine as ac- 
ceptor by the cornea enzyme is in accord 
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Frc. 3. Transfer of [ C-14C]galactose to cornea1 
keratan sulfate and keratan sulfate derivatives with 
time. The assay conditions described under Materials 
and Methods were scaled up 10.fold. Each of the po- 
tential acceptors, agalactokeratan (C), agalactokeratan 
sulfate (x). keratan (a), and keratan sulfate (C), was 
present in the reaction mixtures at a final N- 
acetylglucosamine concentration of 2.0 pmol; the 
added agalactokeratan and agalactokeratan sulfate each 
contained 0.177 pm01 of potential galactosyl acceptor 
sites available to the galactosyltransferase, i.e., the 
amount of galactose removed from each compound. The 
specific activity of the UDP-[ W”C]Gal was 0.5 &ii 
@mol. Incubations were conducted for the periods of 
time indicated. 
with the results obtained with the milk 
A-protein (40). 
Treatment of the ‘“C-labeled product ob- 
tained when agalactokeratan was incubated 
with UDP-[ U-14C]Gal and cornea galactosyl- 
transferase with p-galactosidase resulted in 
the quantitative release of the radioactive 
label as [14C]Gal. After partial acid hydroly- 
sis of [14C]Gal-keratan, 10% of the 14C con- 
tent was identified by paper chromatography 
as galactosyl-(P, 1 + 4)-N-acetylglucosamine 
(Table V). 
Biosynthesis of Keratan Suljate-like 
Polysaccharide by Bovine 
Cornea Fibroblasts 
Fibroblasts isolated from bovine cornea 
stroma were grown in culture medium sup- 
plemented with 10% fetal calf serum. Cells 
(3.8 x 10”) were lysed by freezing and thaw- 
ing and examined for galactosyltransferase 
activity. Persistently low levels (approxi- 
mately 0.2-1.0 enzyme unitimg of protein) 
of galactosyltransferase were detected even 
after six cell passages; the transfer of galac- 
tose from UDP-galactose to glucose was 
enhanced by the addition of u-la&albumin. 
No galactosyltransferase activity (co.01 
enzyme unit/mg of protein) was detected in 
fetal calf serum. 
DISCUSSION 
The purification and characterization of a 
UDP-galactose:keratan sulfate galactosyl- 
transferase prepared from bovine cornea 
have been described. The soluble transferase, 
22,000-fold purified, transfers galactose to 
N-acetylglucosaminyl units terminating 
TABLE IV 
K,,, AND V VALUES OF CORNEALAND MILK GALACTOSYLTRANSFERASES" 
Compound 
Cornea galactosyltransferase Milk A-protein 
v K, L K, 
(nmollmin/U) MM) (nmol/minlU) (mM) 
Iv-Acetylglucosamine 1.00 40.0 1.00 22.0 
Glucose” 0.62 21.0 0.74 12.0 
Agalactokeratan (nasal septum)’ 0.78 2.8 0.63 4.2 
ry-Lactalbumin” 0.012 0.011 
UDP-galactose 0.055 0.066 
MnCI, 0.34 0.54 
I’ Reaction mixtures were similar to those described under Assay of Galactosyltransferases under Materials 
and Methods except that imidazole-NC1 buffer, pH 8.0 and ionic strength 0.5, replaced the cacodylate buffer. 
I’ and K, values were determined by the procedure of Lineweaver and Burk (36). 
h Reaction mixtures contained cu-lactalbumin (15.5 pg) in place of serum albumin. 
( Expressed as the concentration of terminal N-acetylglucosaminyl units available to the transferase. 
” Reaction mixtures contained glucose (2.5 pmol) in place of N-acetylglucosamine. 
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TABLE V 
IDENTIFICATION OF ‘“C-LABELED PRODUCTS OF CORNEA GALACTOSYLTRANSFERASE~ 
Solvent A Solvent B Buffer C 
W-labeled compound obtained (R~a~-m-+mc) (Rod (cm) 
[ WIGal-GlcNAc 1.92 2.6 
After treatment with P-galactosidase 4.30 0.87 10.6 
Partial acid hydrolysate of [l%]Gal-keratan 1.92, 4.35 2.6, 10.6 
After treatment with P-galactosidase 4.30 0.89 10.6 
Reference compounds 
Galactosyl-(P,l + 6)-N-acetylglucosamine 1.44 
Galactosyl-(P, 1 -+ 4)-N-acetylglucosamine 1.90 
Galactosyl-(P, 1 + 3)-N-acetylglucosamine 2.28 2.6 
Galactosyl-(/3,1 + I)-glucose 1.00 
Galactose 4.35 0.89 10.6 
Glucose 1.00 
Mannose 1.13 
u The incubation conditions and conditions for the resolution of the %Xabeled products by paper chroma- 
tography and paper electrophoresis and their detection are described under Materials and Methods. [U-WIGal- 
keratan (300,000 cpm) was partially acid hydrolyzed at 100°C for 2 h in 1 ml of 0.05 N sulfuric acid (38) and 
treated with an excess of an equal amount of Dowex 50 (H+) and Dowex 2 (HCO,-); the neutral fraction was 
reduced in volume and aliquots were used for identification by paper chromatography and paper electrophoresis. 
keratan. The /3,1 + 4 glycosidic linkage 
formed is in accord with the established 
structure of the repeating disaccharide 
comprising keratan sulfate. Enzyme activity 
was assayed with low molecular weight and 
polymeric acceptors at each stage of purifica- 
tion. No changes in the ratios of transferase 
activity were found, suggesting the absence 
of other soluble galactosyltransferases in 
bovine cornea. Small amounts of a second 
galactosyltransferase that catalyzed the 
transfer of galactosyl residues to 3-0-xylosyl 
serine were detected in the particulate 
fraction. 34-p-Xylosyl serine did not serve as 
a galactosyl acceptor for the purified cornea1 
enzyme. This particulate galactosyltrans- 
ferase is believed to be associated with the 
biosynthesis of the linkage region common 
to several glycosaminoglycans (30). 
While the V values for N-acetylglucosamine 
and agalactokeratan as acceptors were simi- 
lar, a markedly lower K, was found with 
agalactokeratan than with N-acetyl-D- 
glucosamine as galactosyl acceptor (Table V). 
Indeed, agalactokeratan may be even a 
better substrate than is suggested by these 
results. The values calculated for aglacto- 
keratan are based on the concentration of 
potential sites (p-N-acetylglucosamine end 
groups exposed) and are not based on the 
actual molar concentrations of the glycos- 
aminoglycan. Since only a limited number 
of terminal N-acetylglucosamine residues 
in the glycosaminoglycan are available to 
the enzyme, expressing concentration in 
terms of glycosaminoglycan rather than 
total N-acetylglucosamine end groups may 
provide a more accurate reflection of the 
relative activity of this acceptor. Neverthe- 
less, we chose the latter method, which 
yields a maximal K, value. The lower K, 
exhibited by agalactokeratan as compared 
to N-acetylglucosamine suggests that the 
chief function of the enzyme is to transfer 
galactose units to terminal N-acetylglucos- 
amine residues of glycoproteins and/or 
keratan and not to free N-acetylglucosamine. 
The fact that low concentrations of agalacto- 
ovomucoid and asialo-agalacto-a,-glycopro- 
tein displayed relatively high galactose 
acceptor activities (Table III) supports this 
conclusion. 
The observed modulation of acceptor 
specificity of the cornea enzyme by (Y- 
la&albumin prompted a comparison of the 
physical and chemical properties of the milk 
BOVINE CORNEA GALACTOSYLTRANSFERASE 557 
A-protein with bovine cornea galactosyl- 
transferase. With the exception of the aber- 
rant staining behavior of the cornea 
transferase on sodium dodecyl sulfate 
polyacrylamide disc gel columns, the milk 
and cornea enzyme preparations appear 
nearly identical with respect to their physi- 
cal characteristics, acceptor specificity, and 
kinetic properties. 
To date, a limited number of studies have 
been concerned with the biosynthesis of 
keratan sulfate. Keratan sulfate I is only 
synthesized in the cornea and by stromal 
fibroblasts (6, 8). Present studies suggest 
that both cornea fibroblasts alone and even 
whole corneas lose their ability to synthesize 
keratan sulfate when incubated in vitro 
(28, 41-43). However, the fibroblasts 
synthesize other glycosaminoglycans, in- 
cluding dermatan sulfate, heparan sulfate, 
and chondroitin-6-sulfate, which are not 
thought to be found in the normal cornea 
(42, 43). The inability of the fibroblasts to 
continue to synthesize keratan sulfate in 
vitro suggests the possibility that galactosyl- 
transferase isolated from bovine cornea may 
not be synthesized by cornea cells but rather 
is obtained from adjacent cells or tissues and 
is subsequently lost during culture; high 
molecular weight compounds found in serum 
such as albumin are known to enter the 
cornea by diffusion (44). In an attempt to 
answer this question, fibroblasts isolated 
from bovine cornea stroma were grown in 
culture medium for extended periods of time 
and assayed for galactosyltransferase activ- 
ity. Low but persistent levels (approximately 
0.2 U/mg of protein) of galactosyltransferase 
were detected even after six cell passages. 
The transfer of galactose from UDP-galactose 
to glucose in the cultured cells was enhanced 
by the addition of a-lactalbumin. These 
results suggest that cornea fibroblasts con- 
tain a constitutive galactosyltransferase 
capable of the addition of galactosyl units 
to enlongating keratan sulfate chains. The 
observed loss of keratan sulfate synthesis 
by cultured cells is therefore probably not 
solely attributable to the loss of cornea 
galactosyltransferase. 
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